Cian Healthcare
add_icon

Cian Healthcare

5.62
-5.62
(-100.00%)
Market Cap
₹- Cr
PE Ratio
-
Volume
0.00
Day High - Low
₹- - ₹-
52W High-Low
₹7.66 - ₹2.97
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
- Cr
EPS
-
PB Ratio
-
Book Value
23.10
EBITDA
-
Dividend Yield
- %
Industry
Healthcare
ROE Growth %
-
Debt to Equity
-
Forecast For
Actual

Company News

View All News
Caret
negative
Cian Healthcare Limited released audited consolidated financial statements for the year ended March 31, 2025, but received a disclaimer of opinion from auditors due to insufficient evidence arising from ongoing Corporate Insolvency Resolution Process (CIRP) affecting both the company and its subsidiary Dr. Smiths Biotech Private Limited. The auditors cited extensive limitations including incomplete records, unverified inventory valuations, missing documentation for assets and liabilities, and inability to assess going concern status, preventing them from forming an audit opinion on the consolidated financial statements.
negative
Cian Healthcare Reports Rs 418.87 Lakh Loss Amid Ongoing Insolvency ProcessNov 15, 2025
Cian Healthcare Limited posted a net loss of Rs 418.87 lakh for the half year ended September 30, 2025, while operating under Corporate Insolvency Resolution Process since August 2024. The company's auditors issued a disclaimer of opinion citing multiple uncertainties including pending creditor claims determination and inability to prepare consolidated results due to its subsidiary also being under insolvency proceedings.
neutral
The National Company Law Tribunal Mumbai Bench has reserved the resolution plan application submitted by Mr. Pradeep Kumar Jain for Cian Healthcare Limited for orders. The hearing was held on November 6, 2025, and the matter was marked as Reserved for Order in CP No. (IB)/149(MB)2022. The resolution plan was previously approved by the Committee of Creditors and submitted to NCLT on October 7, 2025. The company will provide detailed disclosure upon receipt of the written order from NCLT, which will include details on treatment of existing securities, changes to shareholding pattern, and other material disclosures under the approved resolution plan.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
790.15
-
#1 -
-
-
-
-
34.61
699.20
-
#1 -
-
-
-
-
43.29
64.57
-
#1 -
-
-
-
-
21.03
554.80
-
#1 -
-
-
-
-
37.85
28,850.00
-
#1 -
-
-
-
-
39.24
42.05
-
#1 -
-
-
-
-
41.15
54.60
-
#1 -
-
-
-
-
42.72
5,001.00
-
#1 -
-
-
-
-
43.40
414.10
-
#1 -
-
-
-
-
43.97
26.95
-
#1 -
-
-
-
-
41.68
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
TTM
Revenue
58
74
78
69
62
31
0
Expenses
50
62
74
56
51
38
0
EBITDA
8
12
5
13
11
-6
0
Operating Profit %
13 %
16 %
5 %
18 %
18 %
-22 %
0 %
Depreciation
4
4
4
5
6
4
0
Interest
7
8
6
6
6
3
0
Profit Before Tax
-4
1
-6
2
0
-26
0
Tax
0
1
-1
0
-1
0
0
Net Profit
-4
0
-6
2
1
-26
0
EPS in ₹
-1.62
0.02
-2.21
0.81
0.34
-10.39
0.00

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
157
157
166
161
161
156
Fixed Assets
39
37
50
45
39
35
Current Assets
54
63
79
74
72
71
Capital Work in Progress
25
26
13
14
15
15
Investments
5
0
0
0
0
0
Other Assets
87
95
103
102
107
106
Total Liabilities
157
157
166
161
161
156
Current Liabilities
49
58
70
65
66
115
Non Current Liabilities
50
41
41
38
37
9
Total Equity
58
58
56
58
58
32
Reserve & Surplus
35
35
31
33
33
7
Share Capital
23
23
25
25
25
25

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
1
-1
-1
0
-0
17
Investing Activities
-27
3
1
3
-2
-0
Operating Activities
-7
6
9
5
12
21
Financing Activities
36
-10
-11
-7
-10
-4

Share Holding

% Holding
Mar 2021
Sept 2021
Dec 2021
Mar 2022
Sept 2022
Dec 2022
Mar 2023
Sept 2023
Mar 2024
Jun 2024
Sept 2024
Mar 2025
Sept 2025
Promoter
70.89 %
70.89 %
0.00 %
66.26 %
66.26 %
66.26 %
51.85 %
49.62 %
27.10 %
27.10 %
27.10 %
27.10 %
27.10 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.79 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
17.48 %
18.09 %
0.00 %
23.77 %
23.95 %
24.00 %
41.88 %
41.08 %
55.78 %
56.59 %
59.23 %
63.56 %
63.77 %
Others
11.62 %
11.02 %
100.00 %
9.97 %
9.80 %
8.95 %
6.27 %
9.30 %
17.12 %
16.31 %
13.67 %
9.34 %
9.12 %
No of Share Holders
361
385
396
392
424
418
454
672
880
831
1,088
1,501
1,662

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
17 Dec 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
17 Dec 2025 6.19 5.62
08 Oct 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
08 Oct 2024 5.46 4.96

Announcements

Clarification Regarding Extension Of Annual General Meeting (AGM) Of Cian Healthcare Limited (Company).5 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication7 days ago
Corrigendum To The Notice Of 22Nd Annual General Meeting ("AGM") Of The Company Scheduled To Be Held On Wednesday December 17 2025 At 10:00 A.M. Through Video Conferencing/Other Audio-Visual Means.9 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication9 days ago
Reg. 34 (1) Annual Report.10 days ago
Notice Of The 22Nd (Twenty-Second) Annual General Meeting Of The Members Of Cian Healthcare Limited Scheduled To Be Held On Wednesday December 17 2025 At 10:00 A.M. Through Video Conference /Other Audio-Visual Means ("VC / OAVM").10 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 22, 2025
Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 By Cian Healthcare Limited (Company)Nov 21, 2025
Results - Consolidated Financial Results As At 31-03-2025.Nov 18, 2025
Un-Audited Standalone Financial Results For The Half Year Ended September 30 2025Nov 14, 2025
Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by TribunalNov 06, 2025
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsOct 17, 2025
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of CreditorsOct 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Oct 07, 2025
Closure of Trading WindowSep 26, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 18, 2025
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsSep 12, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 11, 2025
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of CreditorsSep 10, 2025
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Sep 03, 2025
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Aug 22, 2025
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Aug 06, 2025
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Aug 05, 2025
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Jul 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Jul 01, 2025
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsJun 24, 2025
Financial Results For Year Ended 31/03/2025Jun 19, 2025
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Jun 05, 2025
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMay 30, 2025
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of CreditorsMay 28, 2025
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)May 24, 2025
Initiation Of CIRP Against Dr. Smiths Biotech Private Limited (CIN: U24246PN2015PTC154818) A Wholly Owned Subsidiary Of The CompanyMay 24, 2025
Corporate Insolvency Resolution Process (CIRP)-Filing of Resolution plan with TribunalMay 24, 2025
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMay 09, 2025
Non-Applicability Of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November 2018 And SEBI Operational Circular No. SEBI/HO/DDHS/P/CIR/2021/613 Dated August 10 2021.Apr 28, 2025
Clarification Letter For Technical Error For Filing Form INC-22 With Respect To Change In Registered Office Of The Company With The MCA Portal.Apr 19, 2025
Reconciliation Of Share Capital Audit Report Under Regulation 76 Of SEBI (Depositories And Participants) Regulations 2018.Apr 19, 2025
Structured Digital Database (SDD) Compliance Certificate Apr 19, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 12, 2025
Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 For The Financial Year Ended 31St March 2025.Apr 07, 2025
Results - Half Yearly Financial Statements For 30Th September 2024.Apr 03, 2025
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMar 29, 2025
Closure of Trading WindowMar 27, 2025
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMar 26, 2025
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of CreditorsMar 22, 2025
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMar 17, 2025
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMar 13, 2025
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMar 07, 2025

Technical Indicators